CARIS LIFE SCIENCES, INC. (CAI) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $178.00K; Long-term Debt, Excluding Current MaturitiesUSD $392.97M; Long-term DebtUSD $392.69M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $173.00K; Long-term Debt, Excluding Current MaturitiesUSD $381.40M; Long-term DebtUSD $381.07M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $169.00K; Long-term Debt, Excluding Current MaturitiesUSD $378.82M; Long-term DebtUSD $378.45M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
CARIS LIFE SCIENCES, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Unamortized Discount USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $178.00K | $392.97M | $392.69M | (m) | (m) | (m) | (m) | (m) | (m) | $7.31M |
| 2026-03-31 | $173.00K | $381.40M | $381.07M | $0.00 | $400.00M | (m) | (m) | $0.00 | $28.30M | $22.93M |
| 2025-12-31 | $169.00K | $378.82M | $378.45M | (m) | (m) | (m) | (m) | (m) | (m) | $25.55M |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $28.30M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $0.00 | $0.00 | $400.00M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $164.00K | $376.30M | $375.88M | $0.00 | $0.00 | $400.00M | $0.00 | $0.00 | $28.30M | $28.12M |
| 2025-06-30 | $95.00K | $373.61M | $373.42M | $0.00 | $0.00 | $400.00M | $0.00 | $0.00 | $28.30M | $30.58M |
| 2024-12-31 | $60.09M | $319.44M | $373.14M | (m) | (m) | (m) | (m) | (m) | $28.30M | $30.86M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |